No Data
No Data
Prime Medicine Price Target Maintained With a $10.00/Share by Citizens Capital Markets
JMP Securities Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $10
H.C. Wainwright Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $10
Express News | Chardan Capital Maintains Buy on Prime Medicine, Maintains $15 Price Target
Prime Medicine Analyst Ratings
J.P. Morgan Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)
Unlock the Full List